ArticleOncotarget2019

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma.

Jennifer Bryant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.